feed,title,long_url,short_url
MedRxiv,"Tocilizumab, netakimab, and baricitinib in patients with mild-to-moderate COVID-19: a retrospective cohort study",https://medrxiv.org/cgi/content/short/2022.03.31.22269942v1?rss=1,https://bit.ly/3uKGThL
